Immune cells track hard-to-target brain tumours
2019
Clinical trials reveal that personalized vaccines can boost immune-cell responses to brain tumours that don’t usually respond to immunotherapy. The findings also point to how to improve such treatments. Personalized vaccines boost immune responses targeting brain tumours.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
10
References
10
Citations
NaN
KQI